|
|
|
What could be better than a week (okay, eight days) that starts with the return of Daylight Saving Time, ends with St. Patrick's Day, and includes Pi Day, the ides of March, and Match Day? Reading the First Opinions that appeared during that span. Topics include health hype with the new Apple Watch, GoFundMe and dubious medical research, making it easier for doctors to prescribe anti-addiction medicine, a not-for-profit company that will shake up the generic drug industry, and more. Follow First Opinion editor Pat Skerrett on Twitter: @PJSkerrett
|
|
|
|
By Larry Husten
Adobe
The Apple Watch can detect atrial fibrillation. But it's even more likely to raise false alarms, which can have harmful consequences.
Read More
|
|
By Marc Harrison
George Frey/Getty Images
Civica Rx, a not-for-profit company formed by three philanthropies and numerous health care organizations, will shake up the marketplace for generic drugs.
Read More
|
|
By Kevin Fiscella and Sarah E. Wakeman
Kristoffer Tripplaar/Sipa USA/AP
Clinicians need a special license to prescribe buprenorphine for opioid use disorder. In the midst of an opioid overdose epidemic, that doesn't make sense.
Read More
|
|
Sponsor content by STAT Expert Advantage
Join our March conference call: Digging into Amarin’s REDUCE-IT data
Join STAT senior writers Matt Herper and Adam Feuerstein, and Dr. Michael Davidson, Professor of Medicine and Director of the Lipid Clinic at the University of Chicago for our first STAT Expert Advantage conference call: Digging into Amarin’s REDUCE-IT data. They’ll discuss the new Vascepa data being presented at the meeting of the American College of Cardiology, its potential impact for patients, and the outlook for Amarin’s business. Become a member of STAT Expert Advantage today to access this fully compliant call — and others like it throughout the year.
|
|
By Kenneth D. Mandl and Arjun K. Manrai
Alissa Ambrose/STAT
Frequent checks to spot disease early can be helpful. They can also drive "biomarkup" — testing driven in part by economics or, put more bluntly, revenue.
Read More
|
|
By Jeremy Snyder
LOIC VENANCE/AFP/Getty Images
Crowdfunding is being used to finance and promote unproven medical treatments and clinical research. GoFundMe should stop being complicit in this.
Read More
|
|
By Justin Chen
Science Source
In the lab, life and death were demythologized. Instead of some immense, cosmic force, they shrank into something that could be contained and studied.
Read More
|
|
By Alison Volpe Holmes and Mona M. Abaza
John Tlumacki/The Boston Globe
The Match, which places half of U.S. medical school graduates in their first-choice programs, is being threatened by the flood of residency applications.
Read More
|
|
By David Friend
Adobe
Proposed changes to HIPAA that would redefine "covered entities" could help people get mental health care, food, secure housing, and other needed services.
Read More
|
|
By Jennifer Bright and Mark Linthicum
Adobe
In the conversation about the value of drugs and health care, the focus is usually on cost. We need to look beyond cost to other things that patients value.
Read More
|
|
By David Johnson
Adobe
The scientific culture in biotech companies should be built out of three major components — respect, openness, and integrity. The acronym (ROI) fits.
Read More
|
